Anxiety and depression are two of the most common mental health disorders in the world.
According to the World Health Organization (WHO), around 264 million individuals globally suffer from depression, while anxiety disorders affect 284 million individuals. These two disorders often co-occur, so diagnosing and treating them effectively is crucial for overall well-being.
What Are Anxiety and Depression?
Anxiety is a normal human emotion that everyone experiences occasionally. However, when anxiety becomes excessive and impacts someone’s ability to carry out their daily activities, a person may have an anxiety disorder.
Anxiety disorders can be debilitating and can negatively impact a person’s quality of life.
Depression is a mood disorder characterized by a persistent feeling of sadness and loss of interest in activities that a person once enjoyed.
Depression can last for weeks or months, and it can impact a person’s overall functioning and quality of life.
Screening Tests for Anxiety and Depression
Screening tests are tools that clinicians use to evaluate whether someone may be experiencing symptoms of anxiety and depression.
These tests are often used in primary care settings, such as family doctor’s offices, and can help identify individuals who may benefit from additional evaluation or treatment.
The following are some common screening tests used for anxiety and depression:.
1. GAD-7
The Generalized Anxiety Disorder 7-item (GAD-7) scale is a brief screening tool used to assess symptoms of generalized anxiety disorder.
Individuals are asked to answer seven items based on their feelings over the past two weeks, with the answers ranging from “not at all” to “nearly every day.”.
The GAD-7 can be used to identify individuals with anxiety disorders and to monitor symptom severity over time. Scores range from 0 to 21, with a score of 10 or above indicating that a person is likely to have an anxiety disorder.
2. PHQ-9
The Patient Health Questionnaire-9 (PHQ-9) is a nine-item screening tool used to evaluate depressive symptoms.
The PHQ-9 is a self-reported questionnaire that asks individuals to rate how often they have experienced depressive symptoms in the past two weeks.
The PHQ-9 scores range from 0 to 27, with higher scores indicating greater symptom severity. A score of 10 or above is suggestive of major depressive disorder, and individuals with this score should be evaluated further to confirm the diagnosis.
3. DASS-21
The Depression Anxiety Stress Scales-21 (DASS-21) is a self-reported questionnaire used to assess the severity of symptoms of depression, anxiety, and stress. The DASS-21 has 21 items and is designed to be easy and quick to administer.
Each subscale has seven items, and scores for each subscale range from 0 to 21. Higher scores indicate greater symptom severity. The DASS-21 can be used to monitor symptom severity over time and to evaluate the effectiveness of treatment.
4. PHQ-4
The Patient Health Questionnaire-4 (PHQ-4) is a four-item screening tool used to evaluate symptoms of depression and anxiety. The PHQ-4 is a brief questionnaire that takes less than a minute to complete and is often used in busy clinical settings.
The PHQ-4 scores range from 0 to 12, and individuals with scores of 6 and above are considered to have a high likelihood of having a depressive or anxiety disorder.
5. Beck Depression Inventory-II
The Beck Depression Inventory-II (BDI-II) is a self-reported questionnaire used to evaluate the severity of depressive symptoms. The BDI-II consists of 21 items, and individuals are asked to rate the severity of each symptom based on a scale of 0 to 3.
Related Article
Free psychiatric assessment tools
The BDI-II scores range from 0 to 63, with higher scores indicating greater symptom severity. The BDI-II is often used to monitor the effectiveness of treatment and to evaluate changes in symptom severity over time.
6. Hamilton Rating Scale for Depression
The Hamilton Rating Scale for Depression (HRSD) is a clinician-administered scale used to evaluate the severity of depressive symptoms.
The HRSD consists of 17 items, and each item is rated on a scale of 0 to 2 or 0 to 4, depending on the severity of the symptom.
The HRSD scores range from 0 to 52, with higher scores indicating greater symptom severity. The HRSD is often used in research studies to evaluate the effectiveness of treatments for depression.
7. Geriatric Depression Scale
The Geriatric Depression Scale (GDS) is a self-reported questionnaire used to evaluate depressive symptoms in older adults. The GDS consists of 30 items and is specifically designed to be easy to administer to older individuals.
The GDS scores range from 0 to 30, with higher scores indicating greater symptom severity. The GDS is often used to evaluate the effectiveness of interventions for depression in older adults.
8. Hospital Anxiety and Depression Scale
The Hospital Anxiety and Depression Scale (HADS) is a self-reported questionnaire used to evaluate symptoms of anxiety and depression.
The HADS consists of 14 items, seven of which relate to depression symptoms and seven that relate to anxiety symptoms.
The HADS scores range from 0 to 21 for each subscale, with higher scores indicating greater symptom severity.
The HADS is often used in clinical settings to evaluate individuals with physical health conditions who may also experience symptoms of anxiety and depression.
9. Montgomery-Asberg Depression Rating Scale
The Montgomery-Asberg Depression Rating Scale (MADRS) is a clinician-administered scale used to evaluate the severity of depressive symptoms.
The MADRS consists of 10 items, and each item is rated on a scale of 0 to 6, with higher scores indicating greater symptom severity.
The MADRS scores range from 0 to 60, with higher scores indicating greater symptom severity. The MADRS is often used in research studies to evaluate the effectiveness of treatments for depression.
10. Zung Self-Rating Depression Scale
The Zung Self-Rating Depression Scale (SDS) is a self-report questionnaire used to evaluate depressive symptoms. The SDS consists of 20 items and is designed to be easy and quick to administer.
The SDS scores range from 20 to 80, with higher scores indicating greater symptom severity. The SDS is often used to evaluate the effectiveness of treatment and to monitor changes in symptom severity over time.
Conclusion
Anxiety and depression are two of the most common mental health disorders that can have a significant impact on a person’s overall well-being.
Screening tests can help identify individuals who may be experiencing symptoms of anxiety and depression and may benefit from further evaluation or treatment.
There are many different screening tests available for anxiety and depression, and clinicians can choose the one that best suits their needs.
By using these tests, clinicians can help individuals get the support they need to manage their symptoms and improve their overall quality of life.
